SuperworthIntensity Therapeutics shares outstanding INTS
Diluted shares outstanding, averaged over each quarter, from 2022.
- Latest quarter, to Jun 30, 2026
- 2.7M
- On a year earlier
- +258.6%
- more shares
Intensity Therapeutics had 2.7M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 258.6% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 2.3M | +303% |
| FY2024 | 575.9K | +5% |
| FY2023 | 548.4K | +302% |
| FY2022 | 136.4K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 2.7M | +259% | |
| Q1 FY26 | 2.5M | +317% | |
| Q4 FY25 | 2.3M | +303% | |
| Q3 FY25 | 1.7M | +212% | |
| Q2 FY25 | 754.7K | +38% | |
| Q1 FY25 | 606.9K | +11% | |
| Q4 FY24 | 575.9K | +5% | |
| Q3 FY24 | 552.2K | +1% | |
| Q2 FY24 | 548.5K | +290% | |
| Q1 FY24 | 548.4K | +302% | |
| Q4 FY23 | 548.4K | +302% | |
| Q3 FY23 | 546.4K | +301% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Intensity Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.